Proteomic Analysis of Effects of Spironolactone in HFpEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction
Circ Heart Fail 2022 Sep 01;15(9)e009693, A Javaheri, A Diab, L Zhao, C Qian, JB Cohen, P Zamani, A Kumar, Z Wang, C Ebert, J Maranville, E Kvikstad, M Basso, V van Empel, AM Richards, RN Doughty, E Rietzschel, K Kammerhoff, J Gogain, P Schafer, DA Seiffert, DA Gordon, F Ramirez-Valle, DL Mann, TP Cappola, JA ChirinosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.